{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:47Z","timestamp":1740144167544,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The global prevalence of diabetes mellitus (DM) continues to rise and 70% of diabetic individuals have dry eye disease (DED) that leads to subsequent abnormalities of the corneal epithelium, corneal nerves, tear film, or corneal endothelium. In addition, persons with diabetes produce fewer tear secretions than healthy individuals. While several anti-inflammatory drug-based therapies for dry eye in diabetic individuals are currently being administered, their efficacy has not been studied in detail. Therefore, the aim of this study was to compare the effectiveness of 3% diquafosol (DQS) vs 0.1% hyaluronic acid (HA) eye drops in diabetic dry eye patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This triple-blind randomized, control trial will include 202 diabetic-related DED and will be assigned to DQS (<jats:italic>n<\/jats:italic> = 101) and HA (<jats:italic>n<\/jats:italic> = 101) one drop, six times per day for 8 weeks. Tear film lipid layer, non-invasive breakup time,  conjunctivocorneal staining score, corneal sensitivity, tear MMP-9 levels, meibomian gland\u00a0expression and quality, tear meniscus height, corneal nerves, immune\/inflammatory cell change, conjunctival hyperemia, and ocular surface disease index questionnaire score will be assessed and compared at baseline, week 4, and week 8.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study will be a standardized, scientific, clinical trial designed to evaluate the therapeutic effects and safety of DQS and HA for diabetic dry eye treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.govNCT05682547. Registered on\u00a0December 05, 2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07818-8","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T10:02:29Z","timestamp":1702375349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A protocol for a single center, randomized, controlled trial comparing the clinical efficacy of 3% diquafosol and 0.1% hyaluronic acid in diabetic patients with dry eye disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiayan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingze","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salissou","family":"Moutari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sile","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0848-827X","authenticated-orcid":false,"given":"Emmanuel Eric","family":"Pazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingru","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"7818_CR1","doi-asserted-by":"crossref","unstructured":"Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389:2239\u201351. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28190580\/. Cited 2022 Nov 24.","DOI":"10.1016\/S0140-6736(17)30058-2"},{"key":"7818_CR2","doi-asserted-by":"crossref","unstructured":"Weisman A, Fazli GS, Johns A, Booth GL. Evolving trends in the epidemiology, risk factors, and prevention of type 2 diabetes: a review. Can J Cardiol. 2018;34:552\u201364. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29731019\/.\u00a0Cited 2022 Nov 24.","DOI":"10.1016\/j.cjca.2018.03.002"},{"key":"7818_CR3","doi-asserted-by":"crossref","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31518657\/.\u00a0Cited 2023 Oct 18.","DOI":"10.1016\/j.diabres.2019.107843"},{"key":"7818_CR4","doi-asserted-by":"crossref","unstructured":"Abdelkader H, Patel D v, Mcghee CN, Alany RG. New therapeutic approaches in the treatment of diabetic keratopathy: a review. Clin Exp Ophthalmol. 2011;39:259\u201370. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20973888\/.\u00a0Cited 2022 Nov 24.","DOI":"10.1111\/j.1442-9071.2010.02435.x"},{"key":"7818_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3801570","volume-title":"Ocular complications of diabetes and therapeutic approaches","author":"VJ Vieira-Potter","year":"2016","unstructured":"Vieira-Potter VJ, Karamichos D, Lee DJ. Ocular complications of diabetes and therapeutic approaches. Biomed Res Int., Hindawi Limited; 2016."},{"key":"7818_CR6","doi-asserted-by":"crossref","unstructured":"El-Agamy A, Alsubaie S. Corneal endothelium and central corneal thickness changes in type 2 diabetes mellitus. Clin Ophthalmol. 2017;11:481\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28280298\/.\u00a0Cited 2022 Nov 24.","DOI":"10.2147\/OPTH.S126217"},{"key":"7818_CR7","doi-asserted-by":"crossref","unstructured":"Lee JS, Oum BS, Choi HY, Lee JE, Cho BM. Differences in corneal thickness and corneal endothelium related to duration in diabetes. Eye (Lond). 2006;20:315\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15832184\/.\u00a0Cited 2022 Nov 24.","DOI":"10.1038\/sj.eye.6701868"},{"key":"7818_CR8","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2147\/OPTH.S242764","volume":"14","author":"A Dota","year":"2020","unstructured":"Dota A, Sakamoto A, Nagano T, Murakami T, Matsugi T. Effect of diquafosol ophthalmic solution on airflow-induced ocular surface disorder in diabetic rats. Clinical Ophthalmol. 2020;14:1019\u201324.","journal-title":"Clinical Ophthalmol."},{"key":"7818_CR9","doi-asserted-by":"crossref","unstructured":"Kaido M, Kawashima M, Shigeno Y, Yamada Y, Tsubota K. Randomized controlled study to investigate the effect of topical diquafosol tetrasodium on corneal sensitivity in short tear break-up time dry eye. Adv Ther. 2018;35:697\u2013706. Available from: https:\/\/link.springer.com\/article\/10.1007\/s12325-018-0685-1.\u00a0Cited 2023 May 6.","DOI":"10.1007\/s12325-018-0685-1"},{"key":"7818_CR10","doi-asserted-by":"crossref","unstructured":"Ji YW, Kim HM, Ryu SY, Oh JW, Yeo A, Choi CY, et al. Changes in human tear proteome following topical treatment of dry eye disease: cyclosporine A versus diquafosol tetrasodium. Invest Ophthalmol Vis Sci. 2019;60:5035\u201344. Available from: http:\/\/cris.nih.go.kr.\u00a0Cited 2023 May 6.","DOI":"10.1167\/iovs.19-27872"},{"key":"7818_CR11","doi-asserted-by":"crossref","unstructured":"Park Y, Song JS, Choi CY, Yoon KC, Lee HK, Kim HS. A randomized multicenter study comparing 0.1%, 0.15%, and 0.3% sodium hyaluronate with 0.05% cyclosporine in the treatment of dry eye. J Ocul Pharmacol Ther. 2017;33:66\u201372. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27929721\/.\u00a0Cited 2023 May 6.","DOI":"10.1089\/jop.2016.0086"},{"key":"7818_CR12","doi-asserted-by":"crossref","unstructured":"Jeon HS, Hyon JY. The efficacy of diquafosol ophthalmic solution in non-Sj\u00f6gren and Sj\u00f6gren syndrome dry eye patients unresponsive to artificial tear. J Ocul Pharmacol Ther. 2016;32:463\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27294831\/.\u00a0Cited 2023 May 6.","DOI":"10.1089\/jop.2015.0081"},{"key":"7818_CR13","doi-asserted-by":"crossref","unstructured":"Ang BCH, Sng JJ, Wang PXH, Htoon HM, Tong LHT. Sodium hyaluronate in the treatment of dry eye syndrome: a systematic review and meta-analysis. Sci Rep.: Nature Publishing Group; 2017.\u00a0Cited 2023 May 6.","DOI":"10.1038\/s41598-017-08534-5"},{"key":"7818_CR14","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhao L, Deng S, Sun X, Wang N. Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics. J Ophthalmol. 2016;2016. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27213053\/.\u00a0Cited 2023 Oct 18.","DOI":"10.1155\/2016\/8201053"},{"key":"7818_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jtos.2016.09.003","volume":"15","author":"K Tsubota","year":"2017","unstructured":"Tsubota K, Yokoi N, Shimazaki J, Watanabe H, Dogru M, Yamada M, et al. New perspectives on dry eye definition and diagnosis: a consensus report by the Asia Dry Eye Society. Ocular Surface. 2017;15:65\u201376.","journal-title":"Ocular Surface."},{"key":"7818_CR16","unstructured":"Zhang X-M, Zhang Q, Fan Q-X, Zhang C, You Y, Zhang C-G, et al. Reliability of Chinese web-based ocular surface disease index questionnaire in dry eye patients: a randomized, crossover study. Int J Ophthalmol. 2021;14:834\u201343. Available from: http:\/\/ies.ijo.cn\/gjyken\/ch\/reader\/view_abstract.aspx?file_no=20210607&flag=1.\u00a0Cited 2023 May 6."},{"key":"7818_CR17","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Marqu\u00e9s JV, Mart\u00ednez-Albert N, Talens-Estarelles C, Garc\u00eda-L\u00e1zaro S, Cervi\u00f1o A. Repeatability of non-invasive keratograph break-up time measurements obtained using oculus keratograph 5M. Int Ophthalmol. 2021;41:2473\u201383. Available from: https:\/\/link.springer.com\/article\/10.1007\/s10792-021-01802-4.\u00a0Cited 2023 May 6.","DOI":"10.1007\/s10792-021-01802-4"},{"key":"7818_CR18","doi-asserted-by":"crossref","unstructured":"Hosaka E, Kawamorita T, Ogasawara Y, Nakayama N, Uozato H, Shimizu K, et al. Interferometry in the evaluation of precorneal tear film thickness in dry eye. Am J Ophthalmol. 2011;151:18\u201323.e1. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939410005702.\u00a0Cited 2023 May 6.","DOI":"10.1016\/j.ajo.2010.07.019"},{"key":"7818_CR19","doi-asserted-by":"crossref","unstructured":"Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmol. 2008;115:911\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18452765\/.\u00a0Cited 2023 May 6.","DOI":"10.1016\/j.ophtha.2007.06.031"},{"key":"7818_CR20","doi-asserted-by":"crossref","unstructured":"Chao C, Stapleton F, Badarudin E, Golebiowski B. Ocular surface sensitivity repeatability with Cochet-Bonnet esthesiometer. Optom Vis Sci. 2015;92:183\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25546826\/.\u00a0Cited 2023 May 6.","DOI":"10.1097\/OPX.0000000000000472"},{"key":"7818_CR21","doi-asserted-by":"crossref","unstructured":"Messmer EM, von Lindenfels V, Garbe A, Kampik A. Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay. Ophthalmol. 2016;123:2300\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27665213\/.\u00a0Cited 2023 May 6.","DOI":"10.1016\/j.ophtha.2016.07.028"},{"key":"7818_CR22","doi-asserted-by":"crossref","unstructured":"Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, Stern M, et al. Experimentally induced dry eye produces ocular surface inflammation and epithelial disease. Adv Exp Med Biol. 2002;506:647\u201355. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12613973\/.\u00a0Cited 2023 May 6.","DOI":"10.1007\/978-1-4615-0717-8_91"},{"key":"7818_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jfo.2018.03.007","volume":"41","author":"F P\u00e9rez-Bartolom\u00e9","year":"2018","unstructured":"P\u00e9rez-Bartolom\u00e9 F, Sanz-Pozo C, Mart\u00ednez-de la Casa JM, Arriola-Villalobos P, Fern\u00e1ndez-P\u00e9rez C, Garc\u00eda-Feijo\u00f3 J. Assessment of ocular redness measurements obtained with keratograph 5M and correlation with subjective grading scales. J Fr Ophtalmol. 2018;41:836\u201346.","journal-title":"J Fr Ophtalmol."},{"key":"7818_CR24","doi-asserted-by":"crossref","unstructured":"Petropoulos IN, Manzoor T, Morgan P, Fadavi H, Asghar O, Alam U, et al. Repeatability of in vivo corneal confocal microscopy to quantify corneal nerve morphology. Cornea. 2013;32. Available from: https:\/\/journals.lww.com\/corneajrnl\/Fulltext\/2013\/05000\/Repeatability_of_In_Vivo_Corneal_Confocal.21.aspx.\u00a0Cited 2022 Dec 9.","DOI":"10.1097\/ICO.0b013e3182749419"},{"key":"7818_CR25","doi-asserted-by":"crossref","unstructured":"Dougherty BE, Nichols JJ, Nichols KK. Rasch analysis of the Ocular Surface Disease Index (OSDI). Invest Ophthalmol Vis Sci. 2011;52:8630\u20135.\u00a0Cited 2023 May 6.","DOI":"10.1167\/iovs.11-8027"},{"key":"7818_CR26","doi-asserted-by":"crossref","unstructured":"Cui L, Li Y, Lee HS, Yang JM, Choi W, Yoon KC. Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye. Int Ophthalmol. 2018;38:2021\u201330.\u00a0Cited 2023 May 6.","DOI":"10.1007\/s10792-017-0693-1"},{"key":"7818_CR27","doi-asserted-by":"crossref","unstructured":"Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, et al. TFOS DEWS II Report Executive Summary. Ocul Surf. 2017;15:802\u201312.\u00a0Cited 2023 May 6.","DOI":"10.1016\/j.jtos.2017.08.003"},{"key":"7818_CR28","doi-asserted-by":"crossref","unstructured":"Association AD. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u20142020. Diabetes Care. 2020;43:S14\u201331. Available from: https:\/\/diabetesjournals.org\/care\/article\/43\/Supplement_1\/S14\/30640\/2-Classification-and-Diagnosis-of-Diabetes.\u00a0Cited 2023 May 6.","DOI":"10.2337\/dc20-S002"},{"key":"7818_CR29","doi-asserted-by":"crossref","unstructured":"Miura M, Inomata T, Nojiri S, Sung J, Nagao M, Shimazaki J, et al. Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial. BMJ Open. 2022;12. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35105626\/.\u00a0Cited 2023 May 6.","DOI":"10.1136\/bmjopen-2021-052488"},{"key":"7818_CR30","doi-asserted-by":"crossref","unstructured":"Dias AC, Batista TM, Roma LP, M\u00f3dulo CM, Malki LT, Dias LC, et al. Insulin replacement restores the vesicular secretory apparatus in the diabetic rat lacrimal gland. Arq Bras Oftalmol. 2015;78:158\u201363. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26222104\/.\u00a0Cited 2023 May 6.","DOI":"10.5935\/0004-2749.20150041"},{"key":"7818_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0168-8227(02)00244-9","volume":"59","author":"M Ozdemir","year":"2003","unstructured":"Ozdemir M, Buyukbese MA, Cetinkaya A, Ozdemir G. Risk factors for ocular surface disorders in patients with diabetes mellitus. Diabetes Res Clin Pract. 2003;59:195\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12590016\/","journal-title":"Diabetes Res Clin Pract."},{"key":"7818_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/01.ICL.0000162759.79740.46","volume":"31","author":"L Luo","year":"2005","unstructured":"Luo L, Li DQ, Corrales RM, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens. 2005;31:186\u201393.","journal-title":"Eye Contact Lens."},{"key":"7818_CR33","doi-asserted-by":"crossref","unstructured":"Jeganathan VSE, Wang JJ, Wong TY. Ocular associations of diabetes other than diabetic retinopathy. Diabetes Care. 2008;31:1905\u201312. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18753669\/.\u00a0Cited 2022 Dec 7.","DOI":"10.2337\/dc08-0342"},{"key":"7818_CR34","doi-asserted-by":"crossref","unstructured":"Zou X, Lu L, Xu Y, Zhu J, He J, Zhang B, et al. Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study. BMC Ophthalmol. 2018;18 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29747621\/.\u00a0Cited 2023 May 6.","DOI":"10.1186\/s12886-018-0781-7"},{"key":"7818_CR35","doi-asserted-by":"crossref","unstructured":"Yoo TK, Oh E. Diabetes mellitus is associated with dry eye syndrome: a meta-analysis. Int Ophthalmol. 2019;39:2611\u201320. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31065905\/.\u00a0Cited 2023 Oct 18.","DOI":"10.1007\/s10792-019-01110-y"},{"key":"7818_CR36","doi-asserted-by":"crossref","unstructured":"Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol. 2008;8","DOI":"10.1186\/1471-2415-8-10"},{"key":"7818_CR37","doi-asserted-by":"crossref","unstructured":"Najafi L, Malek M, Valojerdi AE, Aghili R, Khamseh ME, Fallah AE, et al. Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus. J Diabetes Complications. 2013;27:459\u201362. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23726741\/.\u00a0Cited 2023 May 6.","DOI":"10.1016\/j.jdiacomp.2013.04.006"},{"key":"7818_CR38","doi-asserted-by":"crossref","unstructured":"Zhao X, Xia S, Chen Y. Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: a meta-analysis of randomized controlled trials. Medic. 2017;96. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28953672\/.\u00a0Cited 2022 Dec 6.","DOI":"10.1097\/MD.0000000000008174"},{"key":"7818_CR39","doi-asserted-by":"crossref","unstructured":"Bayer IS. Hyaluronic acid and controlled release: a review. Molecules. 2020;25. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32517278\/.\u00a0Cited 2023 May 6.","DOI":"10.3390\/molecules25112649"},{"key":"7818_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/jop.2021.0083","volume":"38","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Zhang H, Qin G, Wu Y, Song Y, Yang L, et al. Impact of diquafosol ophthalmic solution on tear film and dry eye symptom in type 2 diabetic dry eye: a pilot study. J Ocul Pharmacol Ther. 2022;38:133\u201340. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35049373\/","journal-title":"J Ocul Pharmacol Ther."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07818-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07818-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07818-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T10:06:35Z","timestamp":1702375595000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07818-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7818"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07818-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"10 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was registered with the trial number NCT05682547 and was conducted in compliance with the tenets of the Declaration of Helsinki and the Institutional Review Board of the He Eye Specialist Hospital, Shenyang, China: IRB (2023) K013.01. Documented informed consent was obtained from all participants in this study. In the present study, all components with any individually identifiable information have been removed from the dataset.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent forms are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"803"}}